Myron W. Wentz Sells 5,304 Shares of USANA Health Sciences, Inc. (USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 5,304 shares of the business’s stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $66.01, for a total value of $350,117.04. Following the completion of the sale, the director now directly owns 12,011,418 shares of the company’s stock, valued at approximately $792,873,702.18. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Shares of USANA Health Sciences, Inc. (NYSE USNA) opened at $65.95 on Wednesday. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $71.00. The firm has a market capitalization of $1,579.91, a PE ratio of 17.42 and a beta of 1.07.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, October 24th. The company reported $1.02 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.11. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. The company had revenue of $261.77 million during the quarter, compared to analyst estimates of $259.52 million. During the same quarter in the previous year, the company posted $2.40 EPS. USANA Health Sciences’s revenue for the quarter was up 3.0% on a year-over-year basis. equities analysts anticipate that USANA Health Sciences, Inc. will post 3.7 earnings per share for the current year.

USANA Health Sciences announced that its board has authorized a share repurchase plan on Tuesday, July 25th that authorizes the company to repurchase $64.60 million in shares. This repurchase authorization authorizes the company to buy up to 46% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s management believes its stock is undervalued.

COPYRIGHT VIOLATION NOTICE: “Myron W. Wentz Sells 5,304 Shares of USANA Health Sciences, Inc. (USNA) Stock” was first reported by Markets Daily and is the sole property of of Markets Daily. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://www.themarketsdaily.com/2017/11/15/myron-w-wentz-sells-5304-shares-of-usana-health-sciences-inc-usna-stock.html.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC lifted its stake in shares of USANA Health Sciences by 10.6% in the 2nd quarter. Renaissance Technologies LLC now owns 1,948,266 shares of the company’s stock valued at $124,884,000 after acquiring an additional 186,600 shares during the last quarter. FMR LLC increased its holdings in USANA Health Sciences by 3.9% during the 2nd quarter. FMR LLC now owns 1,598,143 shares of the company’s stock valued at $102,441,000 after purchasing an additional 60,033 shares during the period. Vanguard Group Inc. increased its holdings in USANA Health Sciences by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 979,726 shares of the company’s stock valued at $62,801,000 after purchasing an additional 25,136 shares during the period. Dimensional Fund Advisors LP increased its holdings in USANA Health Sciences by 5.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 751,018 shares of the company’s stock valued at $43,334,000 after purchasing an additional 40,100 shares during the period. Finally, Schroder Investment Management Group increased its holdings in USANA Health Sciences by 9.0% during the 2nd quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock valued at $36,734,000 after purchasing an additional 47,448 shares during the period. 44.54% of the stock is owned by institutional investors.

A number of equities research analysts have recently weighed in on the company. BidaskClub raised USANA Health Sciences from a “sell” rating to a “hold” rating in a research note on Thursday, October 26th. Pivotal Research lowered their target price on USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a research note on Wednesday, July 26th.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply